Bud Selig says baseball’s new science adviser — Dr. Gary Green — is examining the human growth hormone blood
test that the World Anti-Doping Agency (“WADA”) is peddling but he isn’t sure when
the study will be completed.
This is classic Bud: when he doesn’t want to deal with something he commissions another “study.” I’m assuming that the HGH test study will be complete some time after the “What should we do with the Athletics” study, which has been pending for well over a year now despite the fact that everyone knows what the result will be. I’ve been critical of that particular bit of foot-dragging, but in the case of the HGH test I’m just fine with it.
Why? Because the WADA HGH test is basically useless, because WADA is a publicity and profit-seeking shakedown operation, and that because no one ever calls them on it, Selig is damned if he does and damned if he doesn’t.
As Murray Chass noted yesterday WADA’s head — Dr. Gary Wadler — is the go-to quote of choice whenever a steroids story pops up, selling his organization’s agenda and products as though he were an independent scholar or something. The effect of this is that anyone who exhibits opposition to WADA, even on legitimate grounds, has come to be seen by the media and the public as not being serious about combating PED use. And that’s even the case if the WADA product in question — an HGH blood test — is of dubious efficacy.
Bud Selig and baseball were late to the anti-PED party, but they’re pretty well-versed in it now. They know that WADA’s blood test has caught exactly one offender in several years, and even then it was because the authorities were tipped off about the guy using drugs beforehand. Because of that, they know that it’s probably a useless test that they’d never be able to sell to the players’ union.
But they also know that simply rejecting it out of hand would make them appear soft on PEDs and would lead to a bunch of articles — with critical quotes from Dr. Gary Wadler, natch — excoriating them. Articles that fail to note that the same man tut-tutting baseball is out to make a buck.
So what to do about it? Stall! Commission a study. Punt the issue for several months if not longer. And you know what? It’s the smart play.
The Cleveland Indians just announced that they’ve acquired catcher Chris Gimenez from the Texas Rangers in exchange for cash considerations.
Gimenez knows his way to Progressive Field. Indeed, this will be his third stint with the Indians organization. He was their 19th round pick in the 2004 draft, made his big league debut with the club in 2009 and stayed through the 2010 season. He came back in 2014 for eight games, now he’s back again. He has yet to play in 2016 due to a ankle issue. He as doing minor league rehab before being DFA’d by the Rangers yesterday.
Come back to Cleveland, Chris. You always will have a home in Cleveland.
Last year the Dodgers suspended infielder Erisbel Arruebarrena for the remainder of the season“for repeated failures to comply with his contract.” Arreubarrena appealed his suspension to Major League Baseball and it was reduced to thirty days, though that was said to be a settlement between Arruebarrena and the Dodgers as opposed to a full adjudication.
Here we go again: Gabe Kapler, the Dodgers Director of Player Development, just announced that the Dodgers have suspended Arruebarrena for the rest of 2016 “for repeated failure to comply with the terms of his contract.” No further specifics were given.
Arruebarrena was signed out of Cuba to to a five-year, $25 million deal back in 2013. He played in 22 games in the bigs in 2014, hitting .195. He was dropped from the 40-man roster after that season, however, and after his suspension last year managed to only play in 53 games across three levels. He hit better, but none of his action was above Double-A and he was 25 at the time. He’s played 17 games at Double-A this year and isn’t hitting.
What he was or was not doing with respect to his contract is unclear at the moment, but this isn’t exactly the kind of thing that happens on a daily basis, especially with dudes under contract for $25 million, so we’ll probably hear more eventually.
NEW YORK (AP) Braves right fielder Nick Markakis has left the team because of a family emergency.
Manager Fredi Gonzalez said before Wednesday’s game against the Mets that Markakis had headed home to Maryland. The veteran is expected to be back in time for Friday’s home game against Arizona. Atlanta is off Thursday.
Chase d’Arnaud is starting in right field and Mallex Smith is leading off Wednesday.
Markakis is hitting .281 with no home runs and 20 RBIs.
T.J. Quinn of ESPN’s Outside the Lines reports that another major leaguer — or possibly several of them — will soon be suspended for PEDs. He says that, as was the case with Chris Colabello and others recently, the drug will be Turinabol, which is an old school anabolic steroid. Quinn says that improved testing procedures, which he details in the article, are a likely reason for the spike in Turinabol positives, though it’s also possible that there is a tainted supplement being taken, though he deems that speculative.
What isn’t mentioned is . . . how an ESPN reporter knows a positive test is coming when the drug testing program is supposed to be confidential. Someone with the league or the union must be telling him, right? That’s sort of messed up, no? Will MLB investigate who is leaking such things?
Whatever the case, we’ll soon have a new police blotter item, it seems.